Arterial Dissections After Angioplasty by Long vs Short Time of Balloon Inflation: the Randomized Controlled Trial.
NCT04442802 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2023-11-28
Summary
Background. Arterial dissections represent the typical complication of the percutaneous transluminal angioplasty for femoropopliteal disease and have negative impact upon the outcomes of the treatment.
Objective. The study is aimed to test the hypothesis that a prolonged (6 minutes) time of inflation of angioplasty balloon would reduce the rate of severe arterial dissections and necessity in bailout stenting during the treatment of occlusive-stenotic femoropopliteal lesions in patients with chronic limb threatening ischemia.
Methods. The LOVES trial is a single centre, two parallel groups, controlled trial with 1:1 randomization. Participants will be recruited among the patients hospitalized in Vascular Surgery Department of Institute of Emergency Medicine, Chisinau, Republic of Moldova.
Procedure. Diagnostic angiography of the treated limb will be performed first to confirm the presence of stenosis ≥50% or occlusion in the superficial femoral and/or popliteal artery. After crossing of the lesion patient will be supposed to randomization. In the intervention group the angioplasty balloon will be inflated for 6 minutes. In the control group - for 3 minutes.
Presence and severity (grades A-B or C-F according to NHLBI classification) of dissection will be assessed independently by 3 study investigators basing on completion angiography. Decision to classify the dissection as severe (grade C-F) and to perform the bailout stenting will be done by the agreement between at least 2 investigators.
Sample size. Basing on the results of previous retrospective study investigators expect the 23% rate of severe dissection in study group (6 minutes inflation) and 51% - in control group (3 minutes inflation). Using the probability of type I error of 0.05 and power set at 80% investigators have calculated that 45 patients are required for each group. Anticipating 10% rate of loss to follow-up, 50 patients will be randomized per treatment arm.
Randomization. One hundred patients will be allocated to study or control group by two blocks 1:1 randomization using the free online application Research Randomizer, version 4 (Urbaniak GC, Plous S., 2013, http://www.randomizer.org/).
Follow-up. Three follow up visits at 1, 6 and 12 months are scheduled.
Conditions
- Peripheral Arterial Disease
- Dissection Arterial
Interventions
- PROCEDURE
-
Percutaneous transluminal angioplasty
Under local anesthesia the percutaneous arterial access will be created. Digital subtraction angiography of the whole limb will be performed. Occlusive-stenotic lesion of the superficial femoral and / or popliteal artery will be crossed with a guidewire. The plain old (non drug-eluting) will be positioned in the affected arterial segment and inflated up to nominal pressure. After balloon deflation and extraction the completion angiography will be performed. Presence (yes/no) and severity (grades A-B or C-F according to NHLBI classification) of dissection will be assessed independently by 3 study investigators basing on DSA images in 2 directions. Decision to classify the dissection as severe (grade C-F) and to perform the bailout stenting will be done by the agreement between at least 2 from 3 investigators.
Sponsors & Collaborators
-
Dumitru Casian
lead OTHER
Principal Investigators
-
Dumitru Casian, MD, PhD · Nicolae Testemitanu State University of Medicine and Pharmacy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-24
- Primary Completion
- 2022-06-22
- Completion
- 2023-06-23
Countries
- Moldova
Study Locations
More Related Trials
-
Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study
NCT03023098 ·Status: COMPLETED ·Phase: NA
-
Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion
NCT05894460 ·Status: UNKNOWN
-
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
NCT04242134 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SFA TReatment and vAscular Functions
NCT03811925 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis
NCT02832024 ·Status: UNKNOWN ·Phase: NA
-
Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery
NCT02212470 ·Status: COMPLETED ·Phase: PHASE4
-
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
NCT06527963 ·Status: RECRUITING
-
Drug-Eluting Balloon in Arteriovenous Graft
NCT03388892 ·Status: COMPLETED ·Phase: NA
-
Remote Ischemic Preconditioning on the Prognosis of Patients With Elective PCI Using Drug-coated Balloon
NCT04766749 ·Status: COMPLETED ·Phase: NA
-
Balloon Angioplasty Versus Primary Stenting for the Treatment of Femoropopliteal Artery Chronic Total Occlusions
NCT01268722 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease
NCT02648334 ·Status: COMPLETED ·Phase: NA
-
DEFINITIVE AR Two Year Follow-up Extension Study
NCT02363894 ·Status: COMPLETED
-
Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease
NCT05307263 ·Status: RECRUITING ·Phase: NA
-
Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions
NCT05868564 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis
NCT03504657 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized Study of Cutting Balloon Catheter for CAD
NCT07140822 ·Status: COMPLETED ·Phase: NA
-
Drug-Eluting Balloon Angioplasty Versus Bypass Surgery as First-Line Strategies in Infrageniculate Arterial Disease for Critical Limb Ischemia in Type 2 Diabetic Pacients: a Randomised Controlled Clinical Trial
NCT04760119 ·Status: UNKNOWN ·Phase: NA
-
DCB for Dialysis Access Stent Graft Restenosis
NCT03360279 ·Status: UNKNOWN ·Phase: NA
-
Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease
NCT01366482 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis
NCT01083030 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia
NCT01938872 ·Status: UNKNOWN
-
A Retrospective Study on the Factors of Drug-coated Balloon Restenosis
NCT06620458 ·Status: RECRUITING
-
Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae
NCT02440022 ·Status: COMPLETED ·Phase: PHASE3
-
Arteriovenous Fistula: Conventional Angioplasty vs Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial
NCT03068845 ·Status: UNKNOWN ·Phase: PHASE3
-
Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease
NCT03142347 ·Status: UNKNOWN ·Phase: NA